Online citations, reference lists, and bibliographies.

Association Of Elevated Serum Lipid Levels With Retinal Hard Exudate In Diabetic Retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

Emily Y. Chew, Michael L. Klein, Frederick L. Ferris, Nancy A. Remaley, Robert P. Murphy, K Chantry, Byron J Hoogwerf, Darlene Miller
Published 1996 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE To evaluate the relationship between serum lipid levels, retinal hard exudate, and visual acuity in patients with diabetic retinopathy. DESIGN Observational data from the Early Treatment Diabetic Retinopathy Study. PARTICIPANTS Of the 3711 patients enrolled in the Early Treatment Diabetic Retinopathy Study, the first 2709 enrolled had serum lipid levels measured. MAIN OUTCOME MEASURES Baseline fasting serum lipid levels, best-corrected visual acuity, and assessment of retinal thickening and hard exudate from stereoscopic macular photographs. RESULTS Patients with elevated total serum cholesterol levels or serum low-density lipoprotein cholesterol levels at baseline were twice as likely to have retinal hard exudates as patients with normal levels. These patients were also at higher risk of developing hard exudate during the course of the study. The risk of losing visual acuity was associated with the extent of hard exudate even after adjusting for the extent of macular edema. CONCLUSIONS These data demonstrate that elevated serum lipid levels are associated with an increased risk of retinal hard exudate in persons with diabetic retinopathy. Although retinal hard exudate usually accompanies diabetic macular edema, increasing amounts of exudate appear to be independently associated with an increased risk of visual impairment. Lowering elevated serum lipid levels has been shown to decrease the risk of cardiovascular morbidity. The observational data from the Early Treatment Diabetic Retinopathy Study suggest that lipid lowering may also decrease the risk of hard exudate formation and associated vision loss in patients with diabetic retinopathy. Preservation of vision may be an additional motivating factor for lowering serum lipid levels in persons with diabetic retinopathy and elevated serum lipid levels.



This paper is referenced by
10.1111/ceo.13375
Presence of diabetic retinopathy is associated with worse 10‐year mortality among Indigenous Australians in Central Australia: The Central Australian ocular health study
John Landers (2019)
10.1016/j.ophtha.2014.10.028
Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
Amitha Domalpally (2015)
Visual outcome of laser treatment in diabetic retinopathy.
Subha Shrestha (2007)
10.1016/j.dsx.2018.05.006
Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy.
Kuppuswami Jayashree (2018)
10.1016/j.arcmed.2017.10.003
Total Serum Cholesterol Increases Risk for Development and Progression of Nonproliferative Retinopathy in Patients with Type 1 Diabetes Without Therapeutic Intervention: Prospective, Observational Study.
Tomislav Bulum (2017)
10.3390/biom10040645
High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases
Bjorn Betzler (2020)
10.3390/genes8080207
Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
Fatjon Leti (2017)
10.1097/00006982-200510000-00003
PRIMARY INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR DIABETIC MASSIVE MACULAR HARD EXUDATES
Moncef Khairallah (2005)
10.1167/iovs.13-11849
Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels.
Mariko Sasaki (2013)
10.1016/j.ajo.2012.12.017
Imaging Retinal Pigment Epithelial Proliferation Secondary to PASCAL Photocoagulation In Vivo by Polarization-sensitive Optical Coherence Tomography
Jan Lammer (2013)
10.1159/000326849
Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus
Christoph Wanner (2011)
A Hospital Based Clinical Study of Serum Lipid Profile in Non-Proliferative Diabetic Retinopathy with Type 2 Diabetes Mellitus Patients in Tertiary Health Care-2019
Dr. Anamika Nath (2020)
10.3949/ccjm.72.5.447
Diabetic retinopathy: treating systemic conditions aggressively can save sight.
Stephen H. Sinclair (2005)
10.1038/srep44874
Serum lipid profiles and dyslipidaemia are associated with retinal microvascular changes in children and adolescents
Wei Xiao (2017)
10.1155/2013/920713
Structural Changes in Individual Retinal Layers in Diabetic Macular Edema
Tomoaki Murakami (2013)
Retinopathy in a diabetic population.
Subha Shrestha (2007)
FIELD Study Revealed Fenofibrate Reduced Need for Laser Treatment for Diabetic Retinopathy
Anthony C Keech (2008)
Retina Detection and Analysis of Hard Exudates by Polarization-Sensitive Optical Coherence Tomography in Patients With Diabetic
Jan Lammer (2014)
10.2337/diacare.25.8.1320
Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study.
Hendrik A van Leiden (2002)
Efficacité du traitement par injections intravitréennes de Ranibizumab dans l’œdème maculaire diabétique
M. Addou-Regnard (2015)
10.1136/bjophthalmol-2016-309612
Correlation of retinal arterial wall thickness with atherosclerosis predictors in type 2 diabetes without clinical retinopathy
Shigeta Arichika (2016)
10.1007/s40664-013-0003-3
Diabetische Retinopathie
N. Wahrlich (2014)
STUDIES IN DIABETIC NON-PROLIFERA STUDIES IN DIABETIC NON-PROLIFERA STUDIES IN DIABETIC NON-PROLIFERA STUDIES IN DIABETIC NON-PROLIFERA
Parveen Nargis (2012)
10.1016/j.ophtha.2010.06.019
Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment.
Masafumi Ota (2010)
10.1016/j.ophtha.2009.09.027
Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography.
Gábor Gy Deák (2010)
10.1007/s12291-016-0560-2
Role of Lipids in Retinal Vascular and Macular Disorders
Gunjan Prakash (2016)
10.3109/09286586.2013.868004
Prevalence of Diabetes and Diabetic Retinopathy in a Brazilian Population
Silvana Artioli Schellini (2014)
10.1002/14651858.CD006127.pub2
Blood pressure control for diabetic retinopathy.
Diana V. Do (2015)
10.1007/s00125-009-1377-9
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes
Gunilla Nordin Fredrikson (2009)
Pharmacotherapy for diabetic retinopathy - it is not just a dream.
Snježana Kaštelan (2008)
10.4103/0301-4738.178146
Does tight control of systemic factors help in the management of diabetic retinopathy?
Ramachandran Rajalakshmi (2016)
10.1159/000493858
Short-Term Progression of Diabetic Hard Exudates Monitored with High-Resolution Camera
Prisca Loganadane (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar